PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS
Clinical trials for PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS trials appear
Sign up with your email to follow new studies for PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supplement study explores metabolic effects in healthy volunteers
Knowledge-focused CompletedThis study looked at how a supplement called oleoylethanolamide (OEA) with LipiSperse affects certain metabolic markers in healthy adults. Forty participants aged 30 and older with a BMI between 25 and 35 took part. The goal was to measure changes in blood levels of GLP-1 and oth…
Matched conditions: PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS
Phase: PHASE4 • Sponsor: RDC Clinical Pty Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 12:05 UTC
-
Body chemistry secrets: how your sex and genes process a common drug
Knowledge-focused CompletedThis study looked at how the drug yohimbine is processed in healthy young adults, focusing on differences between men and women and how a specific gene (CYP2D6) affects metabolism. 36 volunteers took a single low dose of yohimbine and caffeine, and researchers measured drug level…
Matched conditions: PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS
Phase: NA • Sponsor: University Medicine Greifswald • Aim: Knowledge-focused
Last updated May 26, 2026 12:05 UTC
-
New drug Y-3 passes first safety check in small human study
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called Y-3 in 20 healthy adults. Participants received a single dose of 40 mg, 60 mg, or a placebo. The goal was to measure drug levels in the blood and check for any side effects, not to treat a disease…
Matched conditions: PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC